We are live on ! Find out more
XENT

Intersect ENT, Inc
XENT

Delisted

XENT was delisted on the 12th of May, 2022.

Back to rankings

106 hedge funds and large institutions have $365M invested in Intersect ENT, Inc in 2017 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 28 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

82% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 11

53% more call options, than puts

Call options by funds: $2.18M | Put options by funds: $1.42M

48% more capital invested

Capital invested by funds: $247M → $365M (+$118M)

29% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 28

2% more funds holding

Funds holding: 104 → 106 (+2)

Holders
106
Holders Change
+2
Holders Change %
+1.92%
% of All Funds
2.64%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
20
Increased
36
Reduced
28
Closed
11
Calls
$2.18M
Puts
$1.42M
Net Calls
+$757K
Net Calls Change
+$4.64M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$23M
2
FLAM
First Light Asset Management
Minnesota
+$9.35M
3
PC
Paulson & Co
New York
+$8.97M
4
PVI
Pura Vida Investments
New York
+$5.43M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.29M

Top Sellers

Rank Fund Capital Flow
1
O
OppenheimerFunds
New York
-$6.82M
2
SAM
Sectoral Asset Management
Quebec, Canada
-$5.49M
3
Barclays
Barclays
United Kingdom
-$3.97M
4
Millennium Management
Millennium Management
New York
-$3.56M
5
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$3.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
26
Sectoral Asset Management
Quebec, Canada
$2.46M -$5.49M -391,697 -73%
PHS
27
PFM Health Sciences
California
$2.39M +$1.96M +139,611 New
TCIM
28
TIAA CREF Investment Management
New York
$2.3M +$68.4K +4,884 +4%
Allianz Asset Management
29
Allianz Asset Management
Germany
$2.21M +$14.4K +1,031 +0.8%
Charles Schwab
30
Charles Schwab
California
$2.07M +$97.5K +6,963 +6%
MOACM
31
Mutual of America Capital Management
New York
$1.85M -$36.1K -2,576 -2%
MC
32
Menta Capital
California
$1.77M -$189K -13,463 -12%
Bank of America
33
Bank of America
North Carolina
$1.77M +$54.5K +3,892 +4%
Goldman Sachs
34
Goldman Sachs
New York
$1.76M -$157K -11,241 -10%
BG
35
Bellevue Group
Switzerland
$1.72M -$420K -30,000 -23%
IHM
36
Iguana Healthcare Management
New York
$1.72M +$350K +25,000 +33%
RA
37
Royce & Associates
New York
$1.61M -$2.62M -186,800 -67%
CS
38
Candriam SCA
Luxembourg
$1.59M +$168K +12,000 +15%
RJA
39
Raymond James & Associates
Florida
$1.48M +$110K +7,838 +10%
FG
40
Formula Growth
Quebec, Canada
$1.36M +$1.11M +79,100 New
TAM
41
Tiverton Asset Management
Delaware
$1.29M – – –
Wells Fargo
42
Wells Fargo
California
$1.25M -$346K -24,700 -25%
QI
43
QS Investors
New York
$1.17M – – –
Jacobs Levy Equity Management
44
Jacobs Levy Equity Management
New Jersey
$1.15M -$744K -53,093 -44%
PCM
45
Penn Capital Management
Pennsylvania
$1.14M -$601K -42,894 -39%
PAM
46
Panagora Asset Management
Massachusetts
$1.08M +$304K +21,675 +53%
TA
47
Teachers Advisors
New York
$1.06M +$29.2K +2,084 +3%
KCM
48
Kornitzer Capital Management
Kansas
$986K -$503K -35,900 -38%
AMI
49
Amica Mutual Insurance
Rhode Island
$944K – – –
TC
50
TFS Capital
Pennsylvania
$882K +$308K +22,024 +75%
1
2
3 4 5

XENT Hedge Fund Activity: Q1 2017 in Review

106 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q1 2017, worth a combined $365M — up 48% from $247M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new XENT positions and 11 closed out — a net gain of 9 holders — while 36 added to existing stakes and 28 trimmed.

The largest buyer was BlackRock, adding an estimated $23M. The largest seller was OppenheimerFunds, exiting entirely with an estimated $6.82M sold.

  • 106 institutional investors held Intersect ENT, Inc (XENT) as of Q1 2017, up from 104 in Q4 2016.
  • Funds reported $365M of Intersect ENT, Inc stock for Q1 2017, up 48% quarter-over-quarter.
  • 20 funds opened new Intersect ENT, Inc positions in Q1 2017 and 11 closed out, a net change of +9 holders.
  • The largest Intersect ENT, Inc buyer in Q1 2017 was BlackRock, an estimated $23M added.
  • The largest Intersect ENT, Inc seller in Q1 2017 was OppenheimerFunds, an estimated $6.82M sold.

Based on aggregated 13F filings for Q1 2017.